Genetic Diagnosis and Subtypes
At a Glance
Senior-Loken syndrome is usually confirmed by genetic testing that finds two pathogenic or likely pathogenic variants in the same gene, one inherited from each parent. A negative test or uncertain variant does not always rule it out, so genetic counseling and additional testing may be needed.
Genetic testing is the most reliable way to confirm a diagnosis of Senior-Loken Syndrome (SLS). Because SLS can look like other conditions and its symptoms often appear at different times, identifying the specific genetic cause helps your medical team understand the biology behind the symptoms [1][2].
The Genetic “Instruction Manual”
Senior-Loken Syndrome is an autosomal recessive condition. Think of your child’s DNA as a set of instruction manuals. We all have two copies of every “manual” (gene)—one inherited from our mother and one from our father.
- Carriers: Parents of a child with SLS are almost always “carriers.” This means they have one working copy of the gene and one non-working copy. Carriers typically have no symptoms and may never know they carry the mutation [3][4].
- Recurrence Risk: When both biological parents are confirmed carriers of a pathogenic mutation in the same gene, each of their future pregnancies has a 25% (1 in 4) chance of having SLS, a 50% chance of being a carrier like their parents, and a 25% chance of inheriting two working copies [3][4]. A genetic counselor can help discuss testing for siblings.
Common Genes in SLS
Several genes can cause SLS. The specific gene involved can provide clues regarding whether eye or kidney symptoms are likely to appear first [5][6].
- CEP290 and IQCB1 (NPHP5): These are frequently reported genes that are often linked to early, severe vision loss (often called Leber Congenital Amaurosis or LCA) [5][7][6].
- NPHP1: This is another common cause, often characterized by kidney issues appearing first. Large “deletions” where the entire NPHP1 gene is missing are very common [6][8].
- Other Genes: Genes like NPHP4, SDCCAG8, and WDR19 can also cause SLS, sometimes with additional symptoms affecting other organs [6][9].
How Testing is Performed
Doctors typically use specialized tests to find these mutations:
- Ciliopathy Panels: A targeted test that looks at a pre-set list of genes known to cause cilia-related diseases [1].
- Whole Exome Sequencing (WES): This looks at all the “protein-coding” regions of your DNA [4].
- Whole Genome Sequencing (WGS): This looks at the entire instruction manual, including the “blank” spaces between genes [10].
Why Some Tests May Be “Negative”
If your child has clear symptoms but genetic testing comes back negative, it does not necessarily mean they don’t have SLS. A clinical diagnosis is still valid, and standard “short-read” sequencing can miss larger patterns [10].
- Missing Pieces (CNVs): Standard tests can miss large deletions or duplications of DNA. A special analysis called CNV analysis or MLPA is often needed [11][12].
- Hidden Mutations: Some mutations hide in deep “intronic” regions or involve mobile-element insertions. These may require advanced methods like RNA studies or optical genome mapping [10][13].
Understanding the Report
A clinical geneticist or genetic counselor should interpret your child’s report. A confirmed autosomal-recessive result typically shows:
- The Gene Name: (e.g., IQCB1 or NPHP1) [3].
- Two Mutations: You are looking for two “pathogenic” or “likely pathogenic” variants [3][4].
- Phase: It should confirm the mutations are in trans, meaning they are on opposite chromosome copies (one from each parent). This is usually proven by testing both parents [10][4].
If your report lists variants of “uncertain significance” (VUS), these cannot be used to confirm or rule out the diagnosis on their own [14].
Common questions in this guide
How is Senior-Loken syndrome confirmed?
Which genes are commonly linked to Senior-Loken syndrome?
What does a negative genetic test mean for a child with SLS symptoms?
What should a Senior-Loken genetic report show?
What is the chance of having another child with Senior-Loken syndrome?
Can parents carry an SLS gene change without symptoms?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Senior-Loken syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific gene was identified, and are there two pathogenic variants listed?
- 2.Did the test include 'deletion and duplication analysis' (CNV testing) to look for missing pieces of DNA, like the common NPHP1 deletion?
- 3.Were both parents tested to confirm that the variants were inherited from different parents (confirmed 'in trans')?
- 4.If the test was negative but symptoms are clear, should we consult a genetic counselor about advanced testing like genome sequencing?
- 5.What is the specific risk of recurrence for our future children, and should our other children be screened?
References
References (14)
- 1
Targeted exome sequencing resolves allelic and the genetic heterogeneity in the genetic diagnosis of nephronophthisis-related ciliopathy.
Kang HG, Lee HK, Ahn YH, et al.
Experimental & molecular medicine 2016; (48()):e251 doi:10.1038/emm.2016.63.
PMID: 27491411 - 2
SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular Diagnosis.
Yahalom C, Volovelsky O, Macarov M, et al.
Retina (Philadelphia, Pa.) 2021; (41(10)):2179-2187 doi:10.1097/IAE.0000000000003138.
PMID: 33512896 - 3
Systemic and Ocular Manifestations of a Ciliopathy: A Case Report of Renal-Retinal Involvement in Senior-Loken Syndrome.
Li M, Li S, Cao Y, et al.
Journal of clinical medicine 2026; (15(5)) doi:10.3390/jcm15052060.
PMID: 41827476 - 4
Compound heterozygous splice site variants in the SCLT1 gene highlight an additional candidate locus for Senior-Løken syndrome.
Katagiri S, Hayashi T, Yoshitake K, et al.
Scientific reports 2018; (8(1)):16733 doi:10.1038/s41598-018-35152-6.
PMID: 30425282 - 5
Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4.
Wang J, Li S, Jiang Y, et al.
American journal of ophthalmology 2023; (252()):188-204 doi:10.1016/j.ajo.2023.03.025.
PMID: 36990420 - 6
Clinical and Genetic Characteristics of Senior-Loken Syndrome Patients in Korea.
Song JR, Jung S, Joo K, et al.
Genes 2025; (16(7)) doi:10.3390/genes16070835.
PMID: 40725491 - 7
Clinical and Molecular Features of a Chinese Cohort With Syndromic and Nonsyndromic Retinal Dystrophies Related to the CEP290 Gene.
Zhu T, Shen Y, Sun Z, et al.
American journal of ophthalmology 2023; (248()):96-106 doi:10.1016/j.ajo.2022.11.023.
PMID: 36493848 - 8
A genotype-to-phenotype approach suggests under-reporting of single nucleotide variants in nephrocystin-1 (NPHP1) related disease (UK 100,000 Genomes Project).
Leggatt G, Cheng G, Narain S, et al.
Scientific reports 2023; (13(1)):9369 doi:10.1038/s41598-023-32169-4.
PMID: 37296294 - 9
Compound heterozygous WDR19 variants associated with nephronophthisis, Caroli disease, refractory epilepsy and congenital bilateral central blindness: Case report.
Tang X, Yi S, Qin Z, et al.
Heliyon 2024; (10(1)):e23257 doi:10.1016/j.heliyon.2023.e23257.
PMID: 38163131 - 10
Long-read technologies identify a hidden LINE-1/ERV1 insertion in IQCB1 as causative variant for Senior-Løken syndrome.
de Bruijn SE, van den Born LI, Derks R, et al.
NPJ genomic medicine 2025; (10(1)):33.
PMID: 40263280 - 11
Genomic Landscape of Sporadic Retinitis Pigmentosa: Findings from 877 Spanish Cases.
Martin-Merida I, Avila-Fernandez A, Del Pozo-Valero M, et al.
Ophthalmology 2019; (126(8)):1181-1188 doi:10.1016/j.ophtha.2019.03.018.
PMID: 30902645 - 12
Expanding the Clinical and Molecular Heterogeneity of Nonsyndromic Inherited Retinal Dystrophies.
Rodríguez-Muñoz A, Aller E, Jaijo T, et al.
The Journal of molecular diagnostics : JMD 2020; (22(4)):532-543 doi:10.1016/j.jmoldx.2020.01.003.
PMID: 32036094 - 13
Long-read sequencing improves the genetic diagnosis of retinitis pigmentosa by identifying an Alu retrotransposon insertion in the EYS gene.
Fernández-Suárez E, González-Del Pozo M, Méndez-Vidal C, et al.
Mobile DNA 2024; (15(1)):9 doi:10.1186/s13100-024-00320-1.
PMID: 38704576 - 14
Clinician-Driven Reanalysis of Exome Sequencing Data From Patients With Inherited Retinal Diseases.
Surl D, Won D, Lee ST, et al.
JAMA network open 2024; (7(5)):e2414198 doi:10.1001/jamanetworkopen.2024.14198.
PMID: 38819824
This page is for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your family’s genetic report and discuss diagnosis, testing, and recurrence risk.